Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
EPA finalizes change to national fine particulate pollution standards
The U.S. Environmental Protection Agency has finalized a change to the National Ambient Air Quality Standard for fine particulate pollution from 12 µg/m3 to 9 µg/m3, according to a press release from the agency.
ARS Pharma continues epinephrine nasal spray studies while awaiting FDA approval
ARS Pharma continues to study the effectiveness and safety of its neffy epinephrine nasal spray as patients with allergies wait for an alternative to autoinjectors for anaphylaxis treatment.
Log in or Sign up for Free to view tailored content for your specialty!
Black children face disparities in food allergy reaction severity
Black children had higher odds for severe food allergy reactions and E usage as well as lower total lifetime epinephrine use than white children, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.
Early exposure in medical school, residency encourages careers in allergy, immunology
Allergists and immunologists often decide to enter the specialty during their residency, primarily because of the work-life balance it offers, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Patients with COVID-19 vaccine reactions may be hesitant to get additional doses
Negative reactions to COVID-19 vaccines such as local skin reactions and hives may drive hesitancy to receive additional doses, according to a study published in Annals of Allergy, Asthma & Immunology.
Allergic conditions linked with more COVID-19 diagnoses, less mortality early in pandemic
Patients with allergic conditions had a greater risk for COVID-19 diagnosis but a lower risk for dying of the disease than patients without these conditions, according to a study published in Annals of Allergy, Asthma & Immunology.
Immune-resetting peptide gets orphan drug designation for eosinophilic esophagitis
The FDA has granted an orphan drug designation to ’1104 from Revolo Biotherapeutics, a first-in-class immune-resetting peptide designed to treat eosinophilic esophagitis, according to a press release.
National Women Physicians Day: Top stories marking accomplishments of women in medicine
Founded in 2017 by the National Day Calendar and the Physician Moms Group, National Women Physicians Day is a time where the medical community can honor the path that female doctors have paved through history.
Mount Sinai partners with Clinique to open center for dermatitis, aging research
Icahn School of Medicine at Mount Sinai and Clinique have partnered to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center, Mount Sinai announced in a press release.
Q&A: Improved outcomes anticipated with dupilumab for children with EoE
Treatment options for children with eosinophilic esophagitis have expanded with the FDA’s approval of dupilumab for those aged 1 to 11 years who weigh at least 15 kg, according to a press release.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read